KDx Diagnostics Inc.

📍 Los Gatos, United States🗓 Founded 2016👥 10 employees💰 Last funded 2020
Medical Device🌐 kdxdiagnostics.com
Website LinkedIn
KDx Diagnostics Inc. pioneers the revolutionary URO17®bladder cancer test, poised to redefine non-invasive detection. As the co-inventor and exclusive licensee of this groundbreaking technology, KDx Diagnostics Inc. has garnered FDA Breakthrough Device Designation, CE-IVD certification, and MHRA approvals for the URO17® test. With extensive testing on thousands of samples and validation through respected peer-reviewed journals, URO17® demonstrates improved sensitivity and specificity as compared to other diagnostic tests and procedures. The URO17® urine test presents a compelling alternative to invasive diagnostics and costly imaging techniques for routine monitoring in the US, while diagnosis and monitoring for outside USA of bladder cancer, potentially setting a new gold standard in bladder cancer diagnosis and monitoring.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in KDx Diagnostics Inc.?
KDx Diagnostics Inc. has 2 investors on record on gritt.io, 2 mid-stage.
When did KDx Diagnostics Inc. last raise funding?
The most recent investment in KDx Diagnostics Inc. recorded on gritt.io was in 2020.
When was KDx Diagnostics Inc. founded?
KDx Diagnostics Inc. was founded in 2016.
What industry is KDx Diagnostics Inc. in?
KDx Diagnostics Inc. operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is KDx Diagnostics Inc. based?
KDx Diagnostics Inc. is headquartered in Los Gatos, United States.